• Insurance 150
  • Posts
  • Messi’s $900M Legs: The Ultimate Risk Benchmark

Messi’s $900M Legs: The Ultimate Risk Benchmark

From 3.2 M annual injuries to $900 M athlete policies, sports insurance is turning predictable pain into a $6.6 B underwriting opportunity.

Good morning, ! This week we’re covering the $6.6B sports injury insurance market, RegTech’s $2.3B funding comeback, and Ardonagh’s $2.5B equity raise fueling global growth. Plus, insights on InsurTech’s reset and oil’s surprising stability.

Join 50+ advertisers who reach our 400,000 executives:  Start Here.

Know someone who would love this? Pass it along—they’ll thank you later! Here’s the link.

DATA DIVE

The Injury Economy

3.2 million injuries. $6.6 billion in premiums. One Messi-sized policy. That’s the 2023 sports insurance market in numbers. With accidents making up 50% of all claims, and ages 5–64 accounting for 85% of all injuries, insurers are being drawn into everything from youth soccer leagues to collegiate NIL deals. But the real money’s at the top: Messi’s legs were once insured for nearly $900M—putting even IPO-ready medtech valuations to shame. The insurance angle? Risk is consistent, payout models are maturing, and underwriting is getting smarter. In sports, injuries are inevitable. Being undercovered? Optional.

TREND OF THE WEEK

RegTech: Bigger Rounds Are Back

RegTech is regaining momentum—and it's doing so with bigger checks. After a mid-2024 lull, Q1 2025 saw $2.3B in global funding, the highest in five quarters, with $1.2B coming from deals over $100M. That’s the first time large-ticket rounds outpaced smaller deals since early 2024.

From a Q3 2024 low of $1.2B, total investment nearly doubled, signaling a renewed appetite for scaling proven platforms rather than seeding early experiments. While deal count data isn’t shown here, the value trend suggests a shift from volume to conviction.

Why it matters: For insurers, banks, and compliance-heavy FIGs, this rebound indicates that RegTech isn’t just surviving—it’s consolidating. Expect more M&A, fewer players, and tighter alignment with enterprise risk workflows. Strategic buyers and PE firms should take note: the window for reasonably priced category leaders may be closing. (More)

The Private Markets Intelligence Summit of the Year

📍 October 15, 2025 | Well& by Durst, NYC

Join 300+ private markets leaders—GPs, LPs, operating partners, and advisors—for a single day of insights, strategy, and dealmaking at the New York Private Capital Summit.

This isn’t another networking event. It’s where strategy meets substance:

→ Keynotes from HarbourVest, Bloomberg, Australian Super
→ Deep-dives on secondaries, direct lending, GenAI, and ESG
→ Practical panels on fund formation, human capital, and tax strategy
→ A spotlight on emerging liquidity tools and NAV-based financing

With over 50 senior speakers from firms like Apollo, KKR, Carlyle, Neuberger Berman, and Warburg Pincus, the Summit is designed for decision-makers driving the next decade of private capital.

Reserve your seat before it sells out: Early Bird Access

MARKET MOVERS

Company (Ticker)

Last Price

5D

UnitedHealth Group Incorporated (UNH)

$ 319.23

4.42%

Ping An Insurance (Group), (2318. HK)

$ 6.35

-0.20%

Elevance Health (ELV)

$ 393.00

4.40%

Chubb Limited (CB)

$ 286.99

0.07%

Allianz SE (ALV. DE)

$ 406.61

1.17%

INSURTECH CORNER

InsurTech’s Hangover Phase

The 2021 InsurTech party was wild: $15.4B raised, half of it in P&C alone. Fast forward to 2024 and funding has sobered up to $4.2B, crawling through a correction with P&C ($1.9B) and Health ($1.3B) still leading. Life Insurance, ever the introvert, stays forgotten at $100M. What’s changed? Investors want less sizzle, more steak—operational efficiency, AI-driven automation, and real revenue. The sector’s no longer trying to “change insurance forever.” It’s just trying to survive the comedown with a viable business model. (More)

DEAL OF THE WEEK

Ardonagh Banks $2.5B to Fuel Global Insurance Spree

Ardonagh Group just closed a $2.5 billion equity round led by Stone Point Capital, giving the PE firm a significant stake and pushing Ardonagh’s valuation to $14 billion. Backers MDP, HPS, and ADIA remain on board, signaling continuity amid scale. The raise comes as Ardonagh leans hard into M&A and tech-enabled distribution, with recent milestones including a $1.5B merger with Markerstudy, the AU$2.3B PSC Insurance buy, and the launch of Ardonagh Intelligence, its in-house data play. With 68 acquisitions in 2024 alone, this raise isn’t just dry powder—it’s jet fuel. (More)

TOGETHER WITH 1440 MEDIA

Seeking impartial news? Meet 1440.

Every day, 3.5 million readers turn to 1440 for their factual news. We sift through 100+ sources to bring you a complete summary of politics, global events, business, and culture, all in a brief 5-minute email. Enjoy an impartial news experience.

MACROECONOMICS

Oil’s Panic Immunity

Despite missiles flying over the Middle East, Brent crude oil barely blinked. The price spike after the U.S. strike on Iranian nuclear sites fizzled fast—from $81.40 to $67.14. This isn’t apathy; it’s evolution. Today’s markets don’t panic—they parse data, track tankers via satellite, and shrug at regional drama. Why? Infrastructure investments (like Saudi Arabia’s Red Sea bypass) and shrinking OPEC clout (now just 33% of global supply) have turned once-catastrophic scenarios into background noise. Still, don’t get too comfortable: a return to $100 crude could kick central banks off their rate-cutting path. Inflation: still the boogeyman. (More)

INTERESTING ARTICLES

TWEET OF THE WEEK

"The biggest risk is not taking any risk. In a world that is changing quickly, the only strategy that is guaranteed to fail is not taking risks."

Mark Zuckerberg